0      0

eSymposia | Antibodies and Vaccines as Drugs for COVID-19


When Size Matters: A Broadly Neutralizing Single Domain Antibody to Prevent and Treat COVID 19


Jan 13, 2021 10:40am ‐ Jan 13, 2021 10:55am

Speaker(s):

You must be logged in and own this session in order to post comments.

Leo OzurumbaDwight
1/13/21 11:46 am

Good day sir. This is now an emerging trend in search for Sarscov-2 Ab drugs- ensuring it's capacity for cross neutralization across emerging strains. Then, not loosing sight of qualities for long lasting protection. Testing mAb with support mAb in cocktails version against Sarscov-2 is also emerging, to support efficacy, as reported from some studies. Nice work sir. Wrm regards. Leo Ozurumba-Dwight

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
Number of hours attended:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content